FTO

Cat.No. Product Name Information Product Use Citations Product Validations
S8837 FB23-2 FB23-2 is a potent and selective FTO inhibitor that directly binds to FTO and selectively inhibits this compound's N6-methyladenosine (m6A) demethylase activity with IC50 of 2.6 μM.
International Journal of Biological Sciences, September 11, 2022, 5753-5769
Redox Biology, November 11, 2025, 103928
International Journal of Molecular Sciences, January 13, 2023, 1624
S9876 Dac51 Dac51 is a potent FTO inhibitor with an IC50 of 0.4 μM for inhibiting FTO demethylation.
Nat Commun, 2025, 16(1):1519
Nature Communications, 2025, 1519
Biomedicines, 2025, 1653
S6291 FB23 FB23 is a potent and selective inhibitor of FTO demethylase with IC50 of 60 nM. This compound directly binds to FTO and selectively inhibits FTO's mRNA N6-methyladenosine (m6A) demethylase activity.
International Journal of Biological Sciences, 2025, 7063-7085
Oncogene, 2022, 41(20):2860-2872
Oncogene, 2022, 2860-2872
S2400 Rheic Acid Rhein (Monorhein, NSC 38629, Rheinic) is an anthraquinone compound enriched in the fresh rhizome of Rheum coreanum Nakai, showing anti-inflammation and antitumor activities. Rhein is an FTO (mRNA N6-methyladenine demethylase) inhibitor and also inhibits AlkB repair enzymes.
Animals (Basel), 2024, 14(16)2434
Cell Chem Biol, 2016, 23(3):415-25
S9946 Bisantrene (CS1)

Bisantrene (CS1, NSC-337766, CL 216,942) is an anthracene derivative with anti-tumor activity and a potent and selective FTO inhibitor.

S4295 Meclofenamate Sodium Meclofenamate Sodium(CI 583) is a dual COX-1/COX-2 inhibitor with IC50 of 40 nM and 50 nM, respectively, used in the treatment of joint, muscular pain, arthritis and dysmenorrhea. This compound is a non-selective gap-junction blocker and a highly selective inhibitor of fat mass and obesity-associated (FTO) enzyme inhibitor.
Gynecological Endocrinology, October 26, 2023, 2276167
Cancer & Metabolism, June 18, 2025, 32
International Journal of Molecular Sciences, January 13, 2023, 1624